IMTX
ImmaticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
IMTX vs peer average
37/100
IMTX vs. peer average (D vs. C)
Grade spread
B 3 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IOVA is the first available peer comparator.
Iovance — cell-therapy specialist with TIL focus; comparable clinical-stage manufacturing and regulatory execution risks.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMTX
Immatics
IOVA
Iovance Biotherapeutics
Grade
D
D
Momentum
11
79
Value
41
41
Sentiment
75
26
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs IOVA
IMTX / IOVA
Grade Position
Below peers
IMTX vs. peer average (D vs. C)
37/100
Momentum
11
IOVAValue
41
IMTXSentiment
75
IMTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMTX
IOVA is the first peer returned for this comparison set.

